Kraig Biocraft Laboratories, Inc. (KBLB)
OTCMKTS · Delayed Price · Currency is USD
0.10995
-0.00117 (-1.05%)
At close: Jun 15, 2026
KBLB Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2.89 | 1.79 | 0.67 | 2.55 | 3.86 | 2.36 |
Short-Term Investments | - | - | - | - | 0.1 | - |
Cash & Short-Term Investments | 2.89 | 1.79 | 0.67 | 2.55 | 3.96 | 2.36 |
Cash Growth | 628.21% | 165.90% | -73.62% | -35.58% | 68.20% | 188.29% |
Inventory | 0.07 | 0.03 | 0.01 | 0.01 | 0.01 | - |
Prepaid Expenses | 0.05 | 0.05 | 0.06 | 0.01 | 0.02 | 0.01 |
Total Current Assets | 3.01 | 1.87 | 0.74 | 2.57 | 3.98 | 2.37 |
Property, Plant & Equipment | 0.19 | 0.2 | 0.13 | 0.16 | 0.15 | 0.22 |
Long-Term Investments | 0.51 | 0.49 | 0.63 | 0.49 | 0.44 | 0.44 |
Other Long-Term Assets | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 |
Total Assets | 3.72 | 2.57 | 1.51 | 3.23 | 4.57 | 3.02 |
Accounts Payable | 9.07 | 0.81 | 0.8 | 0.93 | 0.9 | 0.59 |
Accrued Expenses | 0.07 | 8.09 | 7.15 | 6.26 | 5.42 | 4.96 |
Short-Term Debt | 1.49 | 1.49 | 1.62 | 1.65 | 1.71 | 2.16 |
Current Portion of Long-Term Debt | - | - | - | - | - | 0.06 |
Current Portion of Leases | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 |
Other Current Liabilities | - | - | - | - | - | 0.35 |
Total Current Liabilities | 10.68 | 10.45 | 9.61 | 8.89 | 8.07 | 8.16 |
Long-Term Debt | - | - | - | - | - | 0.1 |
Long-Term Leases | 0.11 | 0.12 | 0.04 | 0.05 | 0.02 | 0.06 |
Total Liabilities | 10.78 | 10.56 | 9.65 | 8.94 | 8.09 | 8.32 |
Common Stock | 32.66 | 31.02 | 27.39 | 27.39 | 27.08 | 22.39 |
Additional Paid-In Capital | 12.67 | 12.43 | 12.29 | 11.35 | 10.83 | 9.89 |
Retained Earnings | -57.65 | -56.71 | -53.09 | -49.69 | -46.66 | -42.81 |
Comprehensive Income & Other | 0.02 | 0.02 | 0.02 | 0.02 | - | 0.02 |
Total Common Equity | -12.3 | -13.24 | -13.39 | -10.92 | -8.74 | -10.51 |
Shareholders' Equity | -7.06 | -8 | -8.15 | -5.71 | -3.52 | -5.3 |
Total Liabilities & Equity | 3.72 | 2.57 | 1.51 | 3.23 | 4.57 | 3.02 |
Total Debt | 1.65 | 1.66 | 1.7 | 1.75 | 1.77 | 2.42 |
Net Cash (Debt) | 1.24 | 0.13 | -1.03 | 0.8 | 2.19 | -0.07 |
Net Cash Growth | - | - | - | -63.30% | - | - |
Net Cash Per Share | 0.00 | 0.00 | -0.00 | 0.00 | 0.00 | -0.00 |
Filing Date Shares Outstanding | 1,113 | 1,100 | 1,043 | 1,038 | 1,033 | 950.91 |
Total Common Shares Outstanding | 1,101 | 1,084 | 1,038 | 1,038 | 1,031 | 927.38 |
Working Capital | -7.67 | -8.58 | -8.87 | -6.31 | -4.09 | -5.8 |
Book Value Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Tangible Book Value | -12.3 | -13.24 | -13.39 | -10.92 | -8.74 | -10.51 |
Tangible Book Value Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Machinery | - | 0.19 | 0.18 | 0.18 | 0.17 | 0.17 |
Leasehold Improvements | - | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |